Wolfe Research analyst Bill Carcache downgraded Ryan Specialty Group to Peer Perform from Outperform without a price target. The analyst cites valuation for the downgrade following the stock’s strong year-to-date performance. The firm maintained 2024 and 2025 estimates following Ryan’s in-line earnings report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty Group on the Brink: Unregistered Securities Sale Could Spell Legal Trouble and Investor Woes
- Ryan Specialty Group backs FY organic revenue growth rate 12.5%-14%
- Ryan Specialty Group updates ACCELERATE 2025 restructuring program
- Ryan Specialty Group reports Q1 adjusted EPS 35c, consensus 35c
- Ryan Specialty Group price target raised to $49 from $47 at JPMorgan